Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 309 followers
Latest posts
Last updated 2 days ago
Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant and breastfeeding women and their children exposed in utero or via breastmilk - with tracked changes
2 days ago
Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant...
Comments received from public consultation on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations III: Pregnant and breastfeeding women (EMA/653036/2019)
2 days ago
Comments received from public consultation on good pharmacovigilance practices (GVP) Product- or...
Guidelines on good pharmacovigilance practices (GVP): Introductory cover note, last updated with final considerations on pregnant and breastfeeding women and their children exposed in utero or via breastmilk
2 days ago
Guidelines on good pharmacovigilance practices (GVP): Introductory cover note, last updated with...
Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant and breastfeeding women and their children exposed in utero or via breastmilk
2 days ago
Guideline on good pharmacovigilance practices (GVP): Product- or population-specific considerations III: Pregnant...
Archive of development of good pharmacovigilance practices
2 days ago
Archive of development of good pharmacovigilance practices
Highlights – 1st European Medicine Agency (EMA) and European Respiratory Society (ERS) bilateral meeting
2 days ago
Highlights – 1st European Medicine Agency (EMA) and European Respiratory Society (ERS)...
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 6, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation...
Human medicines European public assessment report (EPAR): Helicobacter Test INFAI, 13C-urea, Date of authorisation: 14/08/1997, Revision: 22, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Helicobacter Test INFAI, 13C-urea, Date...
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 3, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 16, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation...